Dose-response and Therapeutic Time-window of Compound 21: a Randomized Preclinical Trial in Rat Model of Thromboembolic Stroke

被引：0
|
作者：
Ishrat, Tauheed
Fouda, Abdelrahman Y.
Pillai, Bindu
Eldahshan, Wael
Ahmed, Heba
Waller, Jennifer L.
Ergul, Adviye
Fagan, Susan C.
机构：
[1] Univ Georgia, Augusta, GA USA
[2] Georgia Regents Univ, Augusta, GA USA
来源：
STROKE | 2016年 / 47卷
关键词：
Compound C21; angiotensin type II receptor agonist; embolic middle cerebral artery occlusion; functional outcome; ischemic stroke; Stroke recovery; Angiotensin II; Neuroprotection; Infarct size;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
WP113
引用
收藏
页数：3
相关论文
共 34 条
  • [21] Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model
    Ma, YinZhong
    Li, Li
    Kong, LingLei
    Zhu, ZhiMei
    Zhang, Wen
    Song, JunKe
    Chang, Junlei
    Du, GuanHua
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [22] OCULAR ANAPHYLAXIS INDUCED IN THE RAT BY TOPICAL APPLICATION OF COMPOUND-48/80 - DOSE-RESPONSE AND TIME COURSE STUDY
    ALLANSMITH, MR
    BAIRD, RS
    ROSS, RN
    BARNEY, NP
    BLOCH, KJ
    ACTA OPHTHALMOLOGICA, 1989, 67 : 145 - 153
  • [23] Reduction of brain injury using heparin to inhibit leukocyte accumulation in a rat model of transient focal cerebral ischemia .2. Dose-response effect and the therapeutic window
    Yanaka, K
    Spellman, SR
    McCarthy, JB
    Low, WC
    Camarata, PJ
    JOURNAL OF NEUROSURGERY, 1996, 85 (06) : 1108 - 1112
  • [24] Opening the window: Ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model
    Esmaeeli-Nadimi, Ali
    Kennedy, Derek
    Allahtayakoli, Mohammad
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 764 : 55 - 62
  • [25] Early administration of pyrrolidine dithiocarbamate extends the therapeutic time window of tissue plasminogen activator in a male rat model of embolic stroke
    Wang, Zhongxing
    Shan, Weiran
    Cao, Jiangbei
    Wintermark, Max
    Huang, Wenqi
    Zuo, Zhiyi
    JOURNAL OF NEUROSCIENCE RESEARCH, 2018, 96 (03) : 449 - 458
  • [26] FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model
    Okubo, Seiji
    Igarashi, Hironaka
    Kanamatsu, Tomoyuki
    Hasegawa, Daisuke
    Orima, Hiromitsu
    Katayama, Yasuo
    BRAIN RESEARCH, 2007, 1143 : 221 - 227
  • [27] Effect of Phytosterols on Serum Levels of C-Reactive Protein: A Time- and Dose-Response Meta-analysis of Randomized Controlled Trial
    Aslani, Saeed
    Eslami, Mohammad Masoud
    Fakourizad, Ghasem
    Faiz, Ahmad Faisal
    Mohammadi, Kayhan
    Dehghan, Omid
    Imani, Danyal
    Abbaspour, Alireza
    Jamialahmadi, Tannaz
    Razi, Bahman
    Sahebkar, Amirhossein
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2024, 31 (06) : 613 - 630
  • [28] Adjuvant treatment with GP IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tPA administration in a rat model of embolic stroke
    Zhang, L
    Zhang, ZG
    Zhang, RL
    Chopp, M
    STROKE, 2003, 34 (01) : 272 - 273
  • [29] Estimating dose-response for time to remission with instrumental variable adjustment: the obscuring effects of drug titration in Genome Based Therapeutic Drugs for Depression Trial (GENDEP): clinical trial data
    Jennifer Hellier
    Richard Emsley
    Andrew Pickles
    Trials, 21
  • [30] Estimating dose-response for time to remission with instrumental variable adjustment: the obscuring effects of drug titration in Genome Based Therapeutic Drugs for Depression Trial (GENDEP): clinical trial data
    Hellier, Jennifer
    Emsley, Richard
    Pickles, Andrew
    TRIALS, 2020, 21 (01)
1234